Immediate Neuromuscular Responses of the Obliquus Capitis Inferior Following Upper Cervical Manual Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorFlorida Gulf Coast University
About this trial
This study used a prospective, randomized, repeated-measures experimental design to investigate the immediate effects of two upper cervical manual therapy interventions on craniovertebral angle (CVA), clinician-perceived atlas position, and musculoskeletal ultrasound-derived obliquus capitis inferior (OCI) muscle morphology
Eligibility criteria
This trial accepts healthy volunteersQualifiers
read and understand English
no previous history of cervical spine surgery or traumatic cervical injury
no contraindications to cervical manual therapy
Disqualifiers
any absolute contraindications to cervical manipulation
any other medical condition considered unsafe for manual therapy.
Trial design
Design model
Parallel
Treatments tested in this trial
Thrust long-axis manipulation of C1-C2
Other interventionOne thrust manipulation is provided in the thrust group. a 5 second long axis hold traction of C1-C2 was repeated 3 times in the mobilization group
Treatment groups
80 Participants
are divided into 2 treatment groupsGroup A: Long axis thrust manipulation groupExperimental treatment 1 intervention
Group B: Long axis thrust mobilization groupSham comparator 1 intervention
Trial outcomes
Primary outcomes
1
MSK Ultrasound
MSK Ultrasound measure of the Obliquues Capitis inferior muscle lenght and width
Time frame
before intervention, immediately after, and 24 hours after interventionSecondary outcomes
1
Atlas position
Atlas position relative to the head measured wth palpation of C1 transverse process
Time frame
before intervention, immediately after, and 24 hours after intervention2
Craniovertebral angle
Measure of the Craniovertebral angle using photography
Time frame
before intervention, immediately after, and 24 hours after interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov